Erika Buchholz

Promoter methylation of RASSF1A, RARβ and DAPK predict poor prognosis of patients with malignant mesothelioma

Jürgen R. Fischer, U. Ohnmacht, Norman Rieger et al. · Lung Cancer · 2006 · 95 citations

Medicine, Cancer Biology, Oncology +16

Gefitinib Monotherapy in Chemotherapy-Naive Patients with Inoperable Stage III/IV Non-Small-Cell Lung Cancer

Martin Reck, Erika Buchholz, Kathrin Schott-von-Römer et al. · Clinical Lung Cancer · 2006 · 32 citations

Medicine, Oncology, Pharmacotherapy +7

Cetuximab Attenuates Metastasis and u-PAR Expression in Non–Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity

Dessislava A. Nikolova, Irfan A. Asangani, Laura D. Nelson et al. · Cancer Research · 2009 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17

Standard versus Dose-Intensified Chemotherapy with Sequential Reinfusion of Hematopoietic Progenitor Cells in Small Cell Lung Cancer Patients with Favorable Prognosis

Erika Buchholz, Christian Manegold, Lothar R. Pilz et al. · Journal of Thoracic Oncology · 2007 · 23 citations · Full text

Medicine, Hematology, Oncology +16

A Pilot Trial of Gefitinib in Combination with Docetaxel in Patients with Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Christian Manegold, U. Gatzemeier, Erika Buchholz et al. · Clinical Lung Cancer · 2005 · 19 citations

Medicine, Oncology, Pharmacology +11